BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22177952)

  • 1. Therapeutic effect of genetically modified human neural stem cells encoding cytosine deaminase on experimental glioma.
    Kim JH; Kim JY; Kim SU; Cho KG
    Biochem Biophys Res Commun; 2012 Jan; 417(1):534-40. PubMed ID: 22177952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.
    Lee DH; Ahn Y; Kim SU; Wang KC; Cho BK; Phi JH; Park IH; Black PM; Carroll RS; Lee J; Kim SK
    Clin Cancer Res; 2009 Aug; 15(15):4925-34. PubMed ID: 19638465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
    Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
    Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma.
    Ito S; Natsume A; Shimato S; Ohno M; Kato T; Chansakul P; Wakabayashi T; Kim SU
    Cancer Gene Ther; 2010 May; 17(5):299-306. PubMed ID: 19893595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response.
    Lee SJ; Kim Y; Jo MY; Kim HS; Jin Y; Kim SU; Jin J; Joo KM; Nam DH
    Oncol Rep; 2011 Jan; 25(1):63-8. PubMed ID: 21109958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.
    Kang W; Seol HJ; Seong DH; Kim J; Kim Y; Kim SU; Nam DH; Joo KM
    Oncol Rep; 2013 Sep; 30(3):1101-6. PubMed ID: 23828015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
    Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
    Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy.
    Barresi V; Belluardo N; Sipione S; Mudò G; Cattaneo E; Condorelli DF
    Cancer Gene Ther; 2003 May; 10(5):396-402. PubMed ID: 12719709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural stem cell-based dual suicide gene delivery for metastatic brain tumors.
    Wang C; Natsume A; Lee HJ; Motomura K; Nishimira Y; Ohno M; Ito M; Kinjo S; Momota H; Iwami K; Ohka F; Wakabayashi T; Kim SU
    Cancer Gene Ther; 2012 Nov; 19(11):796-801. PubMed ID: 23018623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and the bystander effect in CD::UPRT/5-FC bi-gene therapy of glioma.
    Shi DZ; Hu WX; Li LX; Chen G; Wei D; Gu PY
    Chin Med J (Engl); 2009 Jun; 122(11):1267-72. PubMed ID: 19567135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models.
    Yi BR; Hwang KA; Aboody KS; Jeung EB; Kim SU; Choi KC
    Stem Cell Res; 2014 Jan; 12(1):36-48. PubMed ID: 24141111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma.
    Shimato S; Natsume A; Takeuchi H; Wakabayashi T; Fujii M; Ito M; Ito S; Park IH; Bang JH; Kim SU; Yoshida J
    Gene Ther; 2007 Aug; 14(15):1132-42. PubMed ID: 17508009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosine deaminase-expressing human neural stem cells inhibit tumor growth in prostate cancer-bearing mice.
    Lee HJ; Doo SW; Kim DH; Cha YJ; Kim JH; Song YS; Kim SU
    Cancer Lett; 2013 Jul; 335(1):58-65. PubMed ID: 23391716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma.
    Kosaka H; Ichikawa T; Kurozumi K; Kambara H; Inoue S; Maruo T; Nakamura K; Hamada H; Date I
    Cancer Gene Ther; 2012 Aug; 19(8):572-8. PubMed ID: 22744211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus.
    Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Yoshida Y; Hamada H; Ohmoto T
    Cancer Gene Ther; 2000 Jan; 7(1):74-82. PubMed ID: 10678359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
    Cunningham C; Nemunaitis J
    Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Treatment of Experimental Spinal Cord Glioma With Dual Gene-Engineered Human Neural Stem Cells.
    Ropper AE; Zeng X; Haragopal H; Anderson JE; Aljuboori Z; Han I; Abd-El-Barr M; Lee HJ; Sidman RL; Snyder EY; Viapiano MS; Kim SU; Chi JH; Teng YD
    Neurosurgery; 2016 Sep; 79(3):481-91. PubMed ID: 26671631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo preclinical low-field MRI monitoring of tumor growth following a suicide-gene therapy in an orthotopic mice model of human glioblastoma.
    Breton E; Goetz C; Kintz J; Accart N; Aubertin G; Grellier B; Erbs P; Rooke R; Constantinesco A; Choquet P
    C R Biol; 2010 Mar; 333(3):220-5. PubMed ID: 20338540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
    Kim SK; Kim SU; Park IH; Bang JH; Aboody KS; Wang KC; Cho BK; Kim M; Menon LG; Black PM; Carroll RS
    Clin Cancer Res; 2006 Sep; 12(18):5550-6. PubMed ID: 17000692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor therapeutic effects of cytosine deaminase and interferon-β against endometrial cancer cells using genetically engineered stem cells in vitro.
    Yi BR; Kang NH; Hwang KA; Kim SU; Jeung EB; Choi KC
    Anticancer Res; 2011 Sep; 31(9):2853-61. PubMed ID: 21868529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.